Best Online Menopause Clinic for Low Libido in 2026

The short answer first

The best online menopause clinic for low libidoin 2026 depends on what’s causing yours. If your desire itself dropped and you want to ask about testosterone for women (off-label in the U.S. and supported for postmenopausal HSDD by major menopause societies), Midi Health prescribes it in 22 states, Joi Women’s Wellness ships to most other states, and Hone Healthcovers 32 states with a biomarker-forward model. If you’re postmenopausal under 65 and want a non-hormone pill, Addyi (flibanserin) was FDA-approved for women under 65 with acquired, generalized HSDD on December 15, 2025— and most “best of” pages haven’t updated yet. If sex hurts because of dryness, Wisp treats that for $99 + about $20 a month, and Alloy’s Sexual Health Bundle ($56.65/month, billed $169.95 for 3 months) goes broader. Evernow has the most complete non-testosterone libido-medication menu we found, including Addyi.

There isn’t one winner here. Any page that crowns one is wrong. Low libido in menopause has four common causes. Each gets treated differently. Each clinic does a different subset. The right answer flips fast based on your state, your insurance, and which cause you actually have.

We did the work. Below: the cause-to-treatment-to-provider map, the state-by-state testosterone map (Midi, Joi, Hone), the FDA-label-accurate Addyi rules after December 2025, the 90-day cost math by protocol, and the honest red flags.

Quick pick — find your row

We match you to the right clinic for your state, your insurance, and the cause of your low libido. Free. We don’t share your info with any provider without your permission.

What we actually verified

What is the best online menopause clinic for low libido?

Why we picked these — and why the answer is not the same for everyone

Most “best of” lists pick one winner and act like your situation doesn’t change the answer. It does. Low libido in menopause has four common causes — and the next section helps you find yours. The 30-second version:

• If your problem is desire itself — you used to think about sex and now you don’t, your body looks healthy, you love your partner, but the spark is gone — testosterone is the most-studied treatment. Midi, Joi, or Hone are the clearest online routes. Addyi is the new non-hormone alternative if you’re postmenopausal under 65.
• If your problem is arousal or pain — you want it mentally but your body won’t show up, or it hurts — your cause is probably GSM. Wisp and Alloy are cheaper, faster fixes.
• If everything fell apart at once — sleep, mood, hot flashes, weight, desire — you need a full menopause workup. Midi, Gennev, or Evernow for ongoing care.
• If you don’t know which one is yours, take the quiz. Sixty seconds, free, no info shared without you saying yes first.

First, figure out which kind of low libido you have

This is the single most important decision in the whole page. Skip it and you’ll pay a clinic for the wrong fix.

The cause-to-treatment-to-provider map

One row describing you? That’s your cause. Two rows describing you?You probably have a layered cause — that’s normal and the quiz handles it.

Can you actually get testosterone for women online?

What “off-label” actually means here

There is no FDA-approved testosterone product for women in the U.S.FDA-approved testosterone products are approved for men with low testosterone tied to a specific medical condition. When a women’s clinic prescribes testosterone for low libido, it’s off-label. The dose is much lower than what men get — usually about 10–20% of the male dose, delivered as a cream or gel.

Because no commercial female-dose testosterone exists in the U.S., the prescription is typically filled as a compounded preparation. Compounded drugs are not FDA-approved— the FDA does not verify compounded drugs for safety, effectiveness, or quality before they’re sold. That doesn’t make compounded testosterone automatically wrong, but it does make patient selection, dosing, pharmacy quality, and monitoring more important. A real clinician will check labs, monitor side effects, and adjust.

What the medical societies actually say

The International Menopause Society’s 2024 white paper adds an important sequencing point: typical menopause hormone therapy (estrogen, plus progesterone if you have a uterus) should usually be started first, so a woman is well-estrogenized before testosterone is added.

Plain English: testosterone is not the first thing every menopausal woman should try. It is well-supported for the specific case of postmenopausal women whose desire itself dropped, who have ruled out other causes, and whose estrogen is already optimized.

Why state matters

Testosterone is a Schedule III controlled substance. States layer their own rules on top of federal rules — some don’t allow controlled-substance prescribing via telehealth at all; some require an in-person visit first. That’s why no single telehealth clinic covers all 50 states for testosterone. State lists change as states change their rules. Confirm at intake.

The state-by-state testosterone telehealth map

Verified May 27, 2026from each provider’s own public pages. State lists move — re-check at intake before signing up.

Joi’s product pages currently conflict on Mississippi — one page excludes it, one doesn’t. We’ve flagged it for confirmation at intake.

If your state has no online testosterone option

You still have good options:

1. Addyi is non-hormonal and FDA-approved for women under 65 (including postmenopausal women under 65) as of December 2025. Available through licensed telehealth plus the Addyi PHILRx home program.
2. Vaginal estrogen — if any part of your low libido is dryness or pain, this helps a lot and is available through Wisp, Alloy, Evernow, and others.
3. In-person care with a clinician trained in menopause. The Menopause Society publishes a free practitioner directory at menopause.org. Many of these clinicians prescribe testosterone for women in-state where telehealth can’t reach.

Addyi for postmenopausal women — what changed in December 2025

For ten years, Addyi was only approved for premenopausal women. If you were 55 and postmenopausal, your doctor couldn’t legally write you Addyi for HSDD on-label. That changed on December 15, 2025. Most “best online menopause clinic” pages on the web were written before that date. They miss this.

What Addyi is and how it works

Addyi (generic name: flibanserin) is a once-a-day oral pill you take at bedtime. It is not a hormone. It is not an as-needed pill like Viagra — you take it every night. Addyi affects dopamine, norepinephrine, and serotonin — three brain chemicals involved in mood, attention, reward, and sexual interest. The exact mechanism is unknown.

The FDA label says you should evaluate whether it’s working at eight weeks. The postmenopausal trial showed a placebo-adjusted improvement of 0.4 satisfying sexual events per 28 days — real, modest on average. Some women see meaningful change, some see modest change, and some see none.

Who qualifies, per the FDA label

The current FDA label approves Addyi for women under 65 with acquired, generalized HSDD — meaning:

• Your low desire is distressing to you.
• Your low desire isn’t fully explained by another medical or mental health condition.
• Your low desire isn’t a medication side effect (especially SSRIs or SNRIs).
• Your low desire isn’t due to a relationship problem or substance use.
• “Acquired” means your desire used to be higher and dropped. “Generalized” means it isn’t tied to one partner or one situation.

Addyi is not approved for women 65 or older, for men, or for sexual performance enhancement.

Side effects, alcohol, and drug interactions

How much it costs (cash vs. insurance)

Through the manufacturer’s PHILRx home-delivery program, Addyi’s cash price is listed at $149/month, with free delivery and the coupon automatically applied. For eligible insured patients, the price can drop to as little as $20/month through the patient assistance program. Coverage varies by plan — call your insurance to confirm, and verify the final price at the PHILRx/Addyi checkout because savings programs change.

Where to actually get it online

• Most menopause-specialty clinics (Midi, Alloy, Winona, Wisp, Pandia, Hers) do not currently list Addyi as a default prescription option. Some clinicians within those clinics may still write it if you ask; some won’t.
• Evernow publicly lists Addyi on its sexual-health prescription menu (alongside Vyleesi, Intrarosa, and an arousal cream), making it unusual among menopause-specialty clinics.
• Some licensed general telehealth platforms will prescribe Addyi if a clinician determines you meet the FDA criteria.
• Addyi.com / PHILRx has its own online-visit and home-delivery flow that handles the prescription and shipping in one place.

One important note about Vyleesi

Vyleesi (bremelanotide) is the other FDA-approved HSDD drug — an as-needed self-injection about 45 minutes before sex. The FDA label approves Vyleesi only for premenopausal womenwith acquired, generalized HSDD. If you’re already through menopause, Vyleesi is not approved for you, regardless of what an ad might suggest.

When the real problem is painful sex or vaginal dryness

The options, ranked by cost

• Cheapest: Wisp. $99 menopause consult, then about $20/month for FDA-approved estradiol vaginal cream. No subscription pressure. HSA/FSA accepted. Right pick if dryness or pain is your main issue and you don’t need a longitudinal menopause platform.
• Broadest sexual-health bundle: Alloy. Sexual Health Bundle: $56.65/month, billed as $169.95 for a three-month supply. Includes vaginal estradiol cream plus Alloy’s O-mazing arousal cream. Alloy does not prescribe testosterone — but for the dryness-and-arousal subset, the pricing is clean and visible.
• Full menopause platform with vaginal estrogen: Evernow. $49/month membership for ongoing access; medications billed separately. Also lists Addyi, Intrarosa, and arousal cream.
• Vaginal DHEA: prasterone (Intrarosa). An FDA-approved vaginal insert that converts to estrogen and testosterone locally inside vaginal tissue. Evernow lists it on its prescription menu.
• Oral pill for painful sex: ospemifene (Osphena). Daily oral pill for GSM. FDA-approved for painful sex. See our painful sex clinic guide for more detail.

Vaginal estrogen has very low systemic absorption — it works locally, and not much reaches the rest of your body. That makes it an option many low-risk breast cancer survivors can consider after non-hormonal options and a conversation with their oncologist. Do not start it on your own if you have a current or past estrogen-sensitive cancer — that conversation comes first.

The best online menopause clinics for low libido, ranked

We pulled every fact from each provider’s own current public pages. We re-verify monthly. Any cell requiring intake or checkout confirmation is flagged.

Midi Health — Best overall if hormone-related and you have PPO insurance

Verified facts (May 27, 2026):

• Testosterone for women available in 22 states: AZ, CA, CO, DC, DE, FL, IL, IN, MA, MD, ME, NJ, NM, NV, NY, OH, OR, PA, TX, UT, VA, WA.
• FDA-approved hormone therapy as default. Testosterone typically dispensed as compounded preparation.
• In-network with most PPO plans.
• Self-pay: $250 initial visit, $150 continued-care visit.
• Not enrolled with Medicaid or Medi-Cal. Not covered by Medicare or Medicare-related plans.
• All 50 states for general menopause care; testosterone limited to 22 states.
• HSA/FSA accepted.

Why it’s #1 for hormone-related low libido:Midi is the only menopause-specialty clinic that combines insurance billing with a testosterone evaluation pathway. PPO coverage drops the real cost well below sticker price, and menopause-trained clinicians don’t dismiss the libido conversation the way a general OB-GYN sometimes does.

Damaging admission: Midi does NOT prescribe testosterone in 28 states. If you live in AL, AR, CT, GA, HI, ID, IA, KS, KY, LA, MI, MN, MS, MO, MT, NE, NH, NC, ND, OK, RI, SC, SD, TN, VT, WV, WI, or WY, Midi is not your testosterone clinic. Joi or Hone usually fills the gap (see state map above). Midi is also not the right fit if your primary insurance is Medicaid or Medicare.

Who should NOT pick Midi: Women outside the 22 testosterone states whose main goal is testosterone. Women on Medicaid or Medicare. Women who want a flat-rate monthly subscription.

Joi Women’s Wellness — Best for testosterone in most states Midi doesn’t cover

Verified facts (May 27, 2026):

• Testosterone for women shipped to most U.S. states. Testosterone-excluded states: AL, AR, CT, DE, GA, HI, LA, MN, MO, NC, ND, OK, PA, RI, SC. Mississippi conflicts on Joi’s own pages — mark as [verify at intake].
• $50/month subscription (billed as $150/quarter). Includes follow-up labs and clinician visits.
• Testosterone injection $59/mo; testosterone cream $69/mo; systemic estradiol capsule $49/mo; estradiol cream $69/mo; estradiol patch $89/mo; vaginal estradiol cream $69/mo; vaginal estradiol suppository $89/mo; progesterone capsule $54/mo; progesterone cream $69/mo.
• Estrogen and progesterone can be sent to your local pharmacy so your insurance can apply.
• HSA/FSA accepted. Testosterone typically dispensed as compounded preparation.

Why it’s here:Joi covers most of the states Midi doesn’t — including chunks of the Midwest, Mountain West, and Pacific Northwest beyond Oregon and Washington. The lab-and-visit-included quarterly subscription is the cleanest model for women who want predictable, ongoing testosterone monitoring.

Damaging admission:Joi does NOT bill insurance for clinician visits — it’s cash-pay for the subscription. If you have a strong PPO and live in a Midi state, Midi will usually beat Joi on real cost.

Who should NOT pick Joi:Women in Joi’s excluded states (look at Hone or in-person care). Women who only want one cheap thing fixed (look at Wisp or Alloy).

Hone Health — Best self-pay biomarker-forward testosterone care in 32 states

Verified facts (May 27, 2026):

• Women’s Premium membership in 32 states: AL, AZ, CA, CO, FL, GA, IL, IN, KY, MD, MA, MI, MS, MO, MT, NE, NV, NM, NC, NY, OH, OK, OR, TN, TX, UT, VT, VA, WA, WV, WI, WY.
• Women’s hormone menu includes testosterone (cream and injection), estradiol patch, Bi-est cream, progesterone, Estrace vaginal cream, Vagifem, and DHEA cream.
• $65 initial blood test, $155/month membership, follow-up labs and consults included, medications billed separately.
• Hone’s general marketing page still shows $149/month — provider-site inconsistency. We’ve used the women’s-specific Premium page as the source of truth; verify final pricing in checkout.
• Primarily self-pay. Testosterone dispensed off-label and typically as a compounded preparation.

Why it’s on the list:For the woman who wants frequent lab work, a biomarker dashboard, and a longevity-medicine framing on top of testosterone optimization, Hone is the most developed option. It also fills important testosterone-access gaps Midi and Joi don’t cover (notably AL, GA, MO, NC, OK).

Who should NOT pick Hone: Women whose main goal is the simplest path to testosterone (Joi is leaner). Women who want insurance to cover anything (Midi is the insurance route). Women whose libido issue is really painful sex or dryness (Wisp or Alloy are cheaper, simpler).

Evernow — Best non-testosterone libido medication menu (and one of the few that lists Addyi)

Verified facts (May 27, 2026):

• $49/month month-to-month; $129 for 3 months; $420/year.
• Optional insurance-eligible video visits; self-pay video visit $150.
• Sexual-health prescriptions on the public menu: Addyi (flibanserin), Vyleesi (premenopausal HSDD only), Intrarosa (prasterone), arousal cream.
• Evernow currently does not prescribe testosterone for women.
• All 50 states + DC.

Damaging admission:Evernow does NOT prescribe testosterone right now. If testosterone is what you specifically want, Evernow isn’t your clinic — go to Midi, Joi, or Hone. Because Evernow hasn’t entered testosterone prescribing, its sexual-health menu has had more attention than most competitors — which is why Addyi, Vyleesi, Intrarosa, and arousal cream are all publicly listed.

Who should NOT pick Evernow: Women whose specific request is testosterone. Women who only need vaginal estrogen at the cheapest path (Wisp).

Wisp — Best cheap path when low libido is driven by vaginal dryness or pain

Verified facts (May 27, 2026):

• Menopause consult: $99 (one-time).
• FDA-approved estradiol vaginal cream from ~$20/month.
• Also lists broader hormone therapy options (estradiol patch, gel, oral; progesterone) if clinically appropriate. Not a testosterone clinic.
• Same-day pharmacy fulfillment in many states. HSA/FSA accepted.

Damaging admission:Wisp is NOT a testosterone clinic and isn’t as full-service as Midi, Gennev, or Hone. If your low libido is desire-driven and you want testosterone in the conversation, Wisp isn’t your clinic. Because Wisp stays focused on streamlined sexual-health prescriptions, the cost is dramatically lower than a full-platform clinic for the dryness-and-pain subset.

Who should NOT pick Wisp: Women with extensive systemic menopause symptoms (hot flashes, night sweats, mood changes, sleep disruption) — a longitudinal platform is a better fit.

Alloy — Best transparent sexual-health bundle (no testosterone, but clean dryness/arousal protocol)

Verified facts (May 27, 2026):

• Sexual Health Bundle: $56.65/month, billed $169.95 for 3 months.
• Estradiol vaginal cream: $39.99/month, billed $119.97 for 3 months.
• Estradiol pill: from $39.99/month. Estradiol patch: from $74.99/month. Progesterone: from $23/month.
• Alloy does not prescribe testosterone for women — its FAQ states so directly.
• HSA/FSA accepted; not insurance-first. Covers most U.S. states.

Who should NOT pick Alloy: Women who want testosterone for women. Women whose biggest complaint is desire loss without dryness or pain — testosterone evaluation is more relevant; look at Midi, Joi, or Hone.

Winona — For the compounded-creams-and-DHEA subset

Verified facts (May 27, 2026):

• Estrogen cream + progesterone from $89/month (compounded).
• Estrogen tablets from $54/month (Winona states FDA-approved).
• Progesterone capsules from $39/month (Winona states FDA-approved).
• DHEA capsules from $24–$27 for a 3-month supply.
• No testosterone for women.
• No membership fee; pay per medication. HSA/FSA accepted; not insurance.

Who should NOT pick Winona: Women whose specific request is testosterone for women (DHEA is a precursor, not a substitute). Women who want insurance to cover the visit.

Gennev — Best for a scheduled doctor visit with insurance

Verified facts (May 27, 2026):

• Self-pay: $250 initial visit, $199 follow-up.
• Insurance accepted with standard copay/deductible.
• FDA-approved hormone therapy by default. Does not default to compounded bioidentical hormones.
• Video appointments available in every state.

Who should NOT pick Gennev:Women who want the lowest entry cost (Evernow’s $49/month is cheaper). Women who want testosterone specifically (Midi, Joi, or Hone).

Honorable mention: Hers

Hers launched a menopause line in October 2025. It lists FDA-approved estradiol (oral, patch, vaginal cream) and progesterone (oral). Hers is not in all 50 states and does not currently prescribe testosterone for women or list Addyi as a default. Pricing and specific plan structures should be verified at checkout. Useful if you already use Hers for hair, weight, or mental health and want one brand.

What does it actually cost?

Cash-pay 90-day cost by protocol

Hidden costs to confirm before you sign up

• Labs. Hone’s $155/month includes follow-up labs; Joi’s $150/quarter includes labs; Midi’s labs run through your insurance or self-pay separately.
• Shipping. Most are free, but verify.
• 3-month billing. Alloy bills as a 3-month supply — that’s quarterly, not monthly.
• Cancellation rules. Some require 30-day notice. Some charge for early cancellation. Read before clicking.
• State availability for testosterone — and labs and follow-ups inside that state. If your state requires an in-person follow-up after a controlled-substance prescription, real cost goes up.
• Insurance prior authorization. Addyi often needs prior auth. Your clinician should handle it, but ask before relying on the lower price.

A real-life cost flip

If you’re in California with a PPO plan, Midi looks expensive at $250 cash for the first visit. But if your PPO covers it, your real cost is a specialist copay (often $30–$50) plus pharmacy — much cheaper than Joi’s $150/quarter subscription, even though Joi’s sticker is lower.

If you’re in Connecticut with the same PPO, Midi doesn’t ship testosterone to you. Joi doesn’t either. So your testosterone path is Hone ($530+ in fees over 90 days, plus medication), Addyi if you’re under 65 and HSDD fits, or in-person care. State and insurance flip the answer. Run the math for your situation.

When you should NOT use online care for low libido

We’d rather lose you on this section than have you sign up for a clinic that can’t handle your case safely. If any situation below describes you, close the page and get an in-person workup first.

The hard “not online” list

• Unexplained vaginal bleeding after menopause. Needs a physical exam and possibly imaging or a biopsy. No telehealth clinic should prescribe systemic estrogen until the bleeding is worked up.
• Current diagnosis of breast cancer or another estrogen-sensitive cancer. Talk to your oncologist before starting any hormone therapy.
• Recent blood clot, stroke, or heart attack. Hormone therapy choice and route matters here. An in-person clinician should manage this.
• Active liver disease. Some medications, including Addyi, are not safe with significant liver problems.
• Possible pregnancy. Some women in perimenopause still ovulate. Get a pregnancy test first.
• A complex medication list (multiple psych meds, complex cardiology regimens, transplant medications) — drug-interaction review needs a clinician with your full chart.
• Severe pelvic pain that hasn’t been examined. That’s an in-person workup.

Where to go instead

The Menopause Society maintains a free directory of Certified Menopause Practitioners at menopause.org. Many of these clinicians prescribe testosterone for women in their own state where telehealth can’t reach, do in-person exams, and handle complex medical situations.

What to ask at your first online visit

Five things to disclose

1. Your full symptom list — not just libido. Hot flashes, night sweats, sleep, mood, brain fog, weight, joint pain, vaginal dryness, urinary symptoms.
2. Cancer history — yours and your immediate family’s (especially breast, uterine, ovarian, colon).
3. Blood clot, stroke, or heart history — yours and your immediate family’s.
4. Current medications and supplements — especially SSRIs, SNRIs, blood thinners, blood pressure medications, and any drug for liver problems.
5. Life-stage context — sleep quality, stress level, relationship dynamics, recent big changes.

Five questions to ask

1. “Given my symptoms, what do you think is the primary cause of my low libido?” A good clinician will name a primary cause and explain why. A clinician who immediately reaches for a prescription without answering this is rushing.
2. “Why this treatment over the alternative?” For example: “Why estradiol patch over oral estradiol?” “Why DHEA over testosterone?” “Why Addyi over testosterone for me?”
3. “If this isn’t working at 8–12 weeks, what’s plan B?” Forces the clinician to think one step ahead.
4. “What labs do you want, and why?” Testosterone needs lab follow-up. Most other menopause prescriptions don’t.
5. “Which side effects should I call you about right away, versus tell you at the follow-up?”

Three red flags — leave if you hear any of these

• “Testosterone is FDA-approved for women.” It isn’t, in the U.S. ACOG confirms there is no FDA-approved testosterone formulation for management of menopausal symptoms.
• “You don’t need to disclose anything — let’s just write the prescription.” A real clinician needs your medical history before prescribing hormones.
• “This compounded cream is the same as the FDA-approved version.” It isn’t. Compounded medications aren’t FDA-reviewed for safety, effectiveness, or quality before sale.

How we ranked these providers

1. Low-libido treatment fit (30%). Does the clinic actually treat the four causes of low libido, or does it just treat hot flashes?
2. Safety and clinical oversight (25%). Real prescribers. Real medical-history review. Real follow-up. Lab work where appropriate. Honest about FDA status and contraindications.
3. Treatment menu transparency (20%). Can a reader see what’s on the menu — testosterone, Addyi, vaginal estrogen, DHEA — before paying for intake?
4. Cost and insurance clarity (15%). Visible pricing. Honest insurance posture. Clear cancellation rules.
5. Access friction including state availability (10%). Where can the clinic actually serve patients?

We did not weight affiliate payout. The HRT Index is an independent comparison resource — primary calls-to-action currently route to our matching quiz, not to provider affiliate links. We did not accept payment from any provider in exchange for ranking position. For the broader head-to-head between the most-compared providers, see Midi vs Alloy vs Winona vs Evernow. For treatment-specific comparisons, see our painful sex clinic guide and full HRT provider guide.

Frequently asked questions

Still not sure which clinic is right for your low libido?

Take our free 60-second matching quiz. You’ll answer a few questions — what your low libido feels like (desire, arousal, pain, or all of it), your state, your insurance, and your treatment preferences. We’ll match you to the best-fit clinic with a backup option, and give you the specific questions to ask in your first consultation.

Free. About 60 seconds. We don’t share your info with any provider without your permission.

Why we built this page

The HRT Index is an independent comparison resource for HRT telehealth providers. We built this page because most “best online menopause clinic” pages on the web don’t actually rank clinics for low libido — they rank clinics for menopause overall and treat libido as a side bullet.

Low libido in midlife is the most common sexual concern menopausal women bring to clinicians. It’s treated very differently across the four common causes. The right clinic for a Florida woman who wants testosterone is a different clinic than the right one for a Connecticut woman whose main issue is painful sex. Both should be able to find their answer in one place.

We re-verify pricing monthly. We re-verify state lists monthly. We re-verify medical and regulatory references quarterly. If you spot something out of date, email us at corrections@thehrtindex.com — we want to fix it.

Last verified: May 27, 2026. Next refresh: June 27, 2026.

Sources

Provider pricing and policies (verified May 27, 2026):

• Midi Health testosterone and pricing: joinmidi.com
• Joi Women’s Wellness HRT: joiandblokes.com
• Hone Health women’s Premium membership: honehealth.com
• Evernow membership and sexual-health prescriptions: evernow.com
• Wisp menopause consult: hellowisp.com
• Alloy Sexual Health Bundle: myalloy.com
• Winona hormone replacement therapy: bywinona.com
• Gennev menopause relief: gennev.com
• Hers menopause: forhers.com

Regulatory references:

• U.S. Food and Drug Administration. Addyi (flibanserin) prescribing information, including December 2025 expansion for HSDD in women under 65. accessdata.fda.gov Addyi label
• U.S. Food and Drug Administration. Vyleesi (bremelanotide) prescribing information, premenopausal HSDD indication.
• U.S. Food and Drug Administration. Testosterone information for postmarket drug safety. fda.gov testosterone
• U.S. Drug Enforcement Administration. Drug Scheduling — testosterone listed as Schedule III. dea.gov
• U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. fda.gov compounding Q&A

Medical society guidelines:

• American College of Obstetricians and Gynecologists. Clinical Consensus No. 6, “Compounded Bioidentical Menopausal Hormone Therapy.” Obstetrics & Gynecology, November 2023.
• American College of Obstetricians and Gynecologists. Clinical Consensus, “Treatment of Urogenital Symptoms in Individuals With a History of Estrogen-Dependent Breast Cancer.” December 2021.
• Davis SR, et al. “Global Consensus Position Statement on the Use of Testosterone Therapy for Women.” Journal of Sexual Medicine, 2019.
• Parish SJ, Simon JA, Davis SR, et al. “International Society for the Study of Women’s Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.” Journal of Sexual Medicine, 2021. PubMed
• The Menopause Society. Practice Pearl on testosterone use for hypoactive sexual desire disorder.
• International Menopause Society. “Menopause and MHT in 2024: addressing the key controversies — an International Menopause Society White Paper.”

Patient quotes attributed to publicly displayed testimonials on Midi Health (joinmidi.com) and Evernow (evernow.com). Individual results vary; testimonials are not medical efficacy claims.